Neuroprotection via inhibition of nitric oxide synthase by bis(7)-tacrine

被引:26
作者
Li, WM [1 ]
Lee, NTK
Fu, HJ
Kan, KKW
Pang, YP
Li, MT
Tsim, KWK
Li, XY
Han, YF
机构
[1] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China
[2] Hong Kong Univ Sci & Technol, Dept Biol, Hong Kong, Hong Kong, Peoples R China
[3] Hong Kong Univ Sci & Technol, Dept Chem, Hong Kong, Hong Kong, Peoples R China
[4] Mayo Fdn Med Educ & Res, Rochester, MN USA
[5] Sun Yat Sen Univ, Zhongshan Med Coll, Dept Pharmacol, Guangzhou, Peoples R China
[6] Sun Yat Sen Univ, Zhongshan Med Coll, Proteom Lab, Guangzhou, Peoples R China
关键词
bis(7)-tacrine; neuroprotection; nitric oxide synthase;
D O I
10.1097/01.wnr.0000209014.09094.72
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Here we report that bis(7)-tacrine, a novel acetylcholinesterase inhibitor, exerts neuroprotective effects by inhibition of nitric oxide synthase. In cortical neurons at 12 days in vitro, bis(7)-tacrine concentration-dependently reduced cell death induced by glutamate, beta-amyloid and (L)-arginine, but not by nitric sodium nitroprusside. N-monomethyl-L-arginine, a nitric oxide synthase inhibitor, also prevented the former three types but not the last type of the cytotoxicity; however, nitric oxide scavengers blocked all of these insults, indicating that nitric oxide mediated these neuronal injuries. Furthermore, with nitric oxide synthase activity assays, it was found that bis(7)-tacrine not only suppressed the activation of nitric oxide synthase caused by glutamate in cortical neurons, but also directly inhibited the activity of nitric oxide synthase in vitro. NeuroReport 17:471-474 (c) 2006 Lippincott Williams & Wilkins.
引用
收藏
页码:471 / 474
页数:4
相关论文
共 18 条
  • [1] Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions
    Aarts, M
    Liu, YT
    Liu, LD
    Besshoh, S
    Arundine, M
    Gurd, JW
    Wang, YT
    Salter, MW
    Tymianski, M
    [J]. SCIENCE, 2002, 298 (5594) : 846 - 850
  • [2] Nitric oxide synthases: structure, function and inhibition
    Alderton, WK
    Cooper, CE
    Knowles, RG
    [J]. BIOCHEMICAL JOURNAL, 2001, 357 (03) : 593 - 615
  • [3] Nitric oxide, cell signaling and cell death
    Blaise, GA
    Gauvin, D
    Gangal, M
    Authier, S
    [J]. TOXICOLOGY, 2005, 208 (02) : 177 - 192
  • [4] Nitric oxide neurotoxicity in neurodegenerative diseases
    Boje, KMK
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 : 763 - 776
  • [5] Structures of nitric oxide synthase isoforms complexed with the inhibitor AR-R17477 suggest a rational basis for specificity and inhibitor design
    Fedorov, R
    Vasan, R
    Ghosh, DK
    Schlichting, I
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (16) : 5892 - 5897
  • [6] Protection against ischemic injury in primary cultured astrocytes of mouse cerebral cortex by bis(7)-tacrine, a novel anti-Alzheimer's agent
    Han, YF
    Wu, DC
    Xiao, XA
    Chen, PMY
    Chung, W
    Lee, NTK
    Pang, YP
    Carlier, PR
    [J]. NEUROSCIENCE LETTERS, 2000, 288 (02) : 95 - 98
  • [7] Amyloid β-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis
    Keil, U
    Bonert, A
    Marques, CA
    Scherping, I
    Weyermann, JR
    Strosznajder, JB
    Müller-Spahn, F
    Haass, C
    Czech, C
    Pradier, L
    Müller, WE
    Eckert, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (48) : 50310 - 50320
  • [8] Novel dimeric acetylcholinesterase inhibitor bis(7)-tacrine, but not donepezil, prevents glutamate-induced neuronal apoptosis by blocking N-methyl-D-aspartate receptors
    Li, WM
    Pi, RB
    Chan, HHN
    Fu, HJ
    Lee, NTK
    Tsang, HW
    Pu, YM
    Chang, DC
    Li, CY
    Luo, JL
    Xiong, KM
    Li, ZW
    Xue, H
    Carlier, PR
    Pang, YP
    Tsim, KWK
    Li, MT
    Han, YF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (18) : 18179 - 18188
  • [9] Bis(7)-tacrine, a novel acetylcholinesterase inhibitor, reverses AF64A-induced deficits in navigational memory in rats
    Liu, J
    Ho, WL
    Lee, NTK
    Carlier, PR
    Pang, YP
    Han, YF
    [J]. NEUROSCIENCE LETTERS, 2000, 282 (03) : 165 - 168
  • [10] Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase - Steps toward novel drugs for treating Alzheimer's disease
    Pang, YP
    Quiram, P
    Jelacic, T
    Hong, F
    Brimijoin, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (39) : 23646 - 23649